Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could potentially expand access to millions of patients and give the Danish company a much-needed fillip in the red-hot market. The first GLP-1 pill specifically for ​obesity, also branded as Wegovy, is a 25-mg oral formulation of semaglutide, the active ingredient in the blockbuster injectable version.

Air China resumed direct flights to North Korea on Monday after a six-year pause. Following the return of rail services, the move signals a major step in reopening the isolated nation after strict pandemic-era border closures.View on euronews

Diesel fuel breached the all-time price record in Germany on Sunday at an average €2. 440 ($2.